clonazepam has been researched along with aspirin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bamford, CR; Gillman, MA; Sandyk, R | 1 |
| Kimura, S; Koide, N; Shimomura, J; Takebe, Y | 1 |
| Goadsby, PJ; Kaube, H | 1 |
| Gastfriend, DR; Sattar, SP | 1 |
| Chen, YL; Hsu, CH; Lau, SC; Liu, IC; Pei, D; Yu, SM | 1 |
| de Cássia Bergamaschi, C; Ferreira, TR; Lopes, LC; Motter, FR | 1 |
1 review(s) available for clonazepam and aspirin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
10 other study(ies) available for clonazepam and aspirin
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Opiates in the restless legs syndrome.
Topics: Acetaminophen; Adult; Aged; Analgesics; Aspirin; Caffeine; Clonazepam; Dextropropoxyphene; Drug Combinations; Female; Humans; Male; Narcotics; Oxycodone; Phenacetin; Restless Legs Syndrome; Temazepam | 1987 |
Plasma protein binding of clonazepam in vitro: interaction with other drugs and the effect of pH and plasma dilution.
Topics: Anticonvulsants; Aspirin; Blood Proteins; Clonazepam; Drug Interactions; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Protein Binding | 1987 |
Anti-migraine compounds fail to modulate the propagation of cortical spreading depression in the cat.
Topics: Analgesics; Animals; Aspirin; Cats; Cerebral Cortex; Clonazepam; Cortical Spreading Depression; Dihydroergotamine; Dizocilpine Maleate; Female; Halothane; Lidocaine; Metoprolol; Migraine Disorders; Receptors, N-Methyl-D-Aspartate; Regional Blood Flow; Ultrasonography, Doppler, Transcranial; Valproic Acid | 1994 |
Visual inspection of medications in preventing unexplained relapses.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Aspirin; Benzodiazepines; Cetirizine; Clonazepam; Depression; Female; Humans; Medication Errors; Middle Aged; Olanzapine; Pirenzepine; Secondary Prevention; Terminology as Topic | 2002 |
Restless legs syndrome/Willis-Ekbom disease in type 2 diabetes as the initial manifestation of Parkinson's disease and major cardiovascular disease.
Topics: Aged; Amines; Analgesics; Anticonvulsants; Antihypertensive Agents; Antiparkinson Agents; Aspirin; Biphenyl Compounds; Carotid Stenosis; Clonazepam; Coronary Artery Disease; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Type 2; Gabapentin; gamma-Aminobutyric Acid; Humans; Hypertension; Irbesartan; Male; Parkinson Disease; Quality of Life; Restless Legs Syndrome; Sleep; Tetrazoles; Treatment Outcome | 2017 |
Potentially inappropriate prescriptions to Brazilian older people with Alzheimer disease: A cross-sectional study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspirin; Brazil; Cardiovascular Agents; Central Nervous System Agents; Clonazepam; Cross-Sectional Studies; Drug Interactions; Female; Humans; Inappropriate Prescribing; Male; Polypharmacy; Quetiapine Fumarate; Sertraline | 2021 |